Tags

Type your tag names separated by a space and hit enter

Improving the identification of priority populations to increase hepatitis B testing rates, 2012.
BMC Public Health. 2016 Feb 01; 16:95.BP

Abstract

BACKGROUND

It is estimated that over 40 % of the 218,000 people with chronic hepatitis B (CHB) in Australia in 2011 are undiagnosed. A disproportionate number of those with undiagnosed infection were born in the Asia-Pacific region. Undiagnosed CHB can lead to ongoing transmission and late diagnosis limits opportunities to prevent progression to hepatocellular carcinoma (HCC) and cirrhosis. Strategies are needed to increase testing for hepatitis B virus (HBV) (including culturally and linguistically diverse communities, Aboriginal and/or Torres Strait Islander (Indigenous) people and people who inject drugs). General practitioners (GPs) have a vital role in increasing HBV testing and the timely diagnosis CHB. This paper describes the impact of a GP-based screening intervention to improve CHB diagnosis among priority populations in Melbourne, Australia.

METHODS

A non-randomised, pre-post intervention study was conducted between 2012 and 2013 with three general practices in Melbourne, Australia. Using clinic electronic health records three priority populations known to be at increased CHB risk in Australia (1: Asian-born patients or patients of Asian ethnicity living in Australia; 2: Indigenous people; or 3): people with a history of injecting drugs were identified and their HBV status recorded. A random sample were then invited to attend their GP for HBV testing and/or vaccination. Baseline and follow-up electronic data collection identified patients that subsequently had a consultation and HBV screening test and/or vaccination.

RESULTS

From a total of 33,297 active patients, 2674 (8 %) were identified as a priority population at baseline; 2275 (85.1 %) of these patients had unknown HBV status from which 338 (14.0 %) were randomly sampled. One-fifth (n = 73, 21.6 %) of sampled patients subsequently had a GP consultation during the study period; only four people (5.5 %) were subsequently tested for HBV (CHB detected in n = 1) and none were vaccinated against HBV.

CONCLUSION

CHB infection is an important long-term health issue in Australia and strategies to increase appropriate and timely testing are required. The study was effective at identifying whether Asian-born patients and patients of Asian had been tested or vaccinated for HBV; however the intervention was not effective at increasing HBV testing.

Authors+Show Affiliations

Centre for Population Health, Burnet Institute, Melbourne, Australia. carolinevg@burnet.edu.au. Department of Epidemiology and Preventative Medicine, Monash University, Melbourne, Australia. carolinevg@burnet.edu.au.Centre for Population Health, Burnet Institute, Melbourne, Australia.Cancer Council Victoria, Melbourne, Australia.WHO Collaborating Centre for Viral Hepatitis, Doherty Institute, Melbourne, Australia. Department of Medicine, University of Melbourne, Melbourne, Australia.GRHANITE™ Health Informatics Unit, Health and Biomedical Informatics Centre, University of Melbourne, Melbourne, Australia.Centre for Population Health, Burnet Institute, Melbourne, Australia. Department of Epidemiology and Preventative Medicine, Monash University, Melbourne, Australia.Cancer Council Victoria, Melbourne, Australia.Centre for Population Health, Burnet Institute, Melbourne, Australia. Department of Epidemiology and Preventative Medicine, Monash University, Melbourne, Australia.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

26832144

Citation

van Gemert, Caroline, et al. "Improving the Identification of Priority Populations to Increase Hepatitis B Testing Rates, 2012." BMC Public Health, vol. 16, 2016, p. 95.
van Gemert C, Wang J, Simmons J, et al. Improving the identification of priority populations to increase hepatitis B testing rates, 2012. BMC Public Health. 2016;16:95.
van Gemert, C., Wang, J., Simmons, J., Cowie, B., Boyle, D., Stoove, M., Enright, C., & Hellard, M. (2016). Improving the identification of priority populations to increase hepatitis B testing rates, 2012. BMC Public Health, 16, 95. https://doi.org/10.1186/s12889-016-2716-7
van Gemert C, et al. Improving the Identification of Priority Populations to Increase Hepatitis B Testing Rates, 2012. BMC Public Health. 2016 Feb 1;16:95. PubMed PMID: 26832144.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Improving the identification of priority populations to increase hepatitis B testing rates, 2012. AU - van Gemert,Caroline, AU - Wang,Julie, AU - Simmons,Jody, AU - Cowie,Benjamin, AU - Boyle,Douglas, AU - Stoove,Mark, AU - Enright,Chris, AU - Hellard,Margaret, Y1 - 2016/02/01/ PY - 2015/08/28/received PY - 2016/01/08/accepted PY - 2016/2/3/entrez PY - 2016/2/3/pubmed PY - 2016/9/7/medline SP - 95 EP - 95 JF - BMC public health JO - BMC Public Health VL - 16 N2 - BACKGROUND: It is estimated that over 40 % of the 218,000 people with chronic hepatitis B (CHB) in Australia in 2011 are undiagnosed. A disproportionate number of those with undiagnosed infection were born in the Asia-Pacific region. Undiagnosed CHB can lead to ongoing transmission and late diagnosis limits opportunities to prevent progression to hepatocellular carcinoma (HCC) and cirrhosis. Strategies are needed to increase testing for hepatitis B virus (HBV) (including culturally and linguistically diverse communities, Aboriginal and/or Torres Strait Islander (Indigenous) people and people who inject drugs). General practitioners (GPs) have a vital role in increasing HBV testing and the timely diagnosis CHB. This paper describes the impact of a GP-based screening intervention to improve CHB diagnosis among priority populations in Melbourne, Australia. METHODS: A non-randomised, pre-post intervention study was conducted between 2012 and 2013 with three general practices in Melbourne, Australia. Using clinic electronic health records three priority populations known to be at increased CHB risk in Australia (1: Asian-born patients or patients of Asian ethnicity living in Australia; 2: Indigenous people; or 3): people with a history of injecting drugs were identified and their HBV status recorded. A random sample were then invited to attend their GP for HBV testing and/or vaccination. Baseline and follow-up electronic data collection identified patients that subsequently had a consultation and HBV screening test and/or vaccination. RESULTS: From a total of 33,297 active patients, 2674 (8 %) were identified as a priority population at baseline; 2275 (85.1 %) of these patients had unknown HBV status from which 338 (14.0 %) were randomly sampled. One-fifth (n = 73, 21.6 %) of sampled patients subsequently had a GP consultation during the study period; only four people (5.5 %) were subsequently tested for HBV (CHB detected in n = 1) and none were vaccinated against HBV. CONCLUSION: CHB infection is an important long-term health issue in Australia and strategies to increase appropriate and timely testing are required. The study was effective at identifying whether Asian-born patients and patients of Asian had been tested or vaccinated for HBV; however the intervention was not effective at increasing HBV testing. SN - 1471-2458 UR - https://www.unboundmedicine.com/medline/citation/26832144/Improving_the_identification_of_priority_populations_to_increase_hepatitis_B_testing_rates_2012_ L2 - https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-016-2716-7 DB - PRIME DP - Unbound Medicine ER -